Showing results (1-10 of 397) with videos related to
Sort By:
Pageof 40
Journal of Internal Medicine. Supplement|January 1, 1997
Iron chelation therapyA V Hoffbrand, B WonkeBailliere'S Clinical Haematology|April 1, 1989
Results of long-term subcutaneous desferrioxamine therapyA V Hoffbrand, B WonkeBritish Journal of Haematology|November 25, 1998
Combined therapy with deferiprone and desferrioxamineB Wonke, C Wright, A V HoffbrandEuropean Journal of Haematology|November 1, 1994
Deferiprone-associated myelotoxicityF N al-Refaie, B Wonke, A V HoffbrandJournal of Clinical Pathology|August 1, 1990
Antibody to hepatitis C virus in multiply transfused patients with thalassaemia majorB Wonke, A V Hoffbrand, D Brown, et al.British Journal of Haematology|May 1, 1994
The effect of deferiprone (L1) and desferrioxamine on myelopoiesis using a liquid culture systemF N al-Rafaie, S Wilkes, B Wonke, et al.Annals of the New York Academy of Sciences|July 21, 1998
New approaches to the management of hepatitis and endocrine disorders in Cooley's anemiaB Wonke, A V Hoffbrand, P Bouloux, et al.Journal of Clinical Pathology|February 1, 1995
Changes in transferrin saturation after treatment with the oral iron chelator deferiprone in patients with iron overloadF N al-Refaie, C E De Silva, B Wonke, et al.British Journal of Haematology|October 29, 2000
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia majorP T Telfer, E Prestcott, S Holden, et al.Obstetrics and Gynecology|October 1, 1988
Hypothalamic-pituitary-gonadal axis in thalassemic patients with secondary amenorrheaV De Sanctis, C Vullo, M Katz, et al.Pageof 40